De Novo Biologics Design: AI-Enabled Approaches to Deliver Better Biologics by Design

  • Shifting from screening-based discovery towards biologics by design through AI momentum and applications
  • Exploring how real impact today is accelerating design-make-test cycles and reducing experimental iteration
  • Recognizing that success requires integrated AI platforms that combine generative models, predictive models, and experimental feedback